Company / Free Cash Flow
IGC Pharma, Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$4.9M
FY2025
5-year range
-$13.1M / -$4.9M
FY2021-FY2025
Trend
+33.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has increased for 4 consecutive years, from -$13M in FY2021 to -$5M in FY2025.
Based on SEC 10-K filings.
-$5M in FY2025.
Improved from -$8M to -$5M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- IGC Pharma, Inc.'s free cash flow has grown for 4 consecutive years.
- In FY2025, free cash flow increased 33.3% year-over-year.
- Peak free cash flow was recorded in FY2017.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -13.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.9M | +33.3% |
| FY2024 | -$7.4M | +4.4% |
| FY2023 | -$7.7M | +37.3% |
| FY2022 | -$12.3M | +6.1% |
| FY2021 | -$13.1M | -290.6% |
| FY2020 | -$3.3M | -61.8% |
| FY2019 | -$2.1M | -34.5% |
| FY2018 | -$1.5M | -449.1% |
| FY2017 | -$279.9K | +89.5% |
| FY2016 | -$2.7M | -52.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026